Linkedin Facebook Twitter Youtube

22 Jul Code Biotherapeutics

Posted at 17:41h in by

Brian McVeigh, Chairman, CEO, and Co-Founder

Oct. 7 | 2:45pm | FLW Ballroom G 

Lower Gwynedd, PA

(Private)

Code Bio is a genetic medicine company pioneering the development of a new class of precision therapies to treat life-threatening genetic diseases. Code Bio’s proprietary, novel, multivalent, non-viral, synthetic, DNA delivery platform ‒ known as 3DNA® ‒ is unlike viral and other nonviral delivery approaches. The 3DNA platform offers more precise cell targeting, the ability to redose, a scalable, modular manufacturing process, and the ability to deliver large genetic payloads. Code Bio is advancing an internal pipeline of candidates while establishing partnerships to develop therapies to treat currently untreatable diseases.

www.codebiotx.com



About the Event

The Cell & Gene Meeting on the Mesa is the sector’s foremost annual conference bringing together senior executives and top decision-makers in the industry to advance cutting-edge research into cures. Tackling the commercialization hurdles facing the cell and gene therapy sector today, this meeting covers a wide range of topics from clinical trial design to alternative payment models to scale-up and supply chain platforms for advanced therapies. The program features expert-led panels, extensive partnering capabilities, exclusive networking opportunities, and 110+ dedicated presentations by the leading publicly traded and privately held companies in the space. Attracting over 2,000 attendees – over 20% of which are C-level executives – this conference enables key partnerships through more than 5,000 one-on-one meetings while highlighting the significant clinical and commercial progress in the field.

Dates & Location

October 6-8, 2025
Arizona Biltmore
Phoenix, AZ

Program Organizer

By using this website you agree to accept our Privacy Policy and Terms & Conditions